You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Journal logo
Sections
Ask the Ethicist
At the Bench
Best Advances
Disease Mechanisms
Diversity
For Your Patients
In the Pipeline
Off the Clock
Neurotech
Letters to the Editor
Policy and Practice
Professionalism
The Science Explained
Wellness
Topics
Behavioral Neurology/Dementia
Cerebrovascular Disease
Child Neurology
Epilepsy
Genetics
Headache/Facial Pain
Movement Disorders
Multiple Sclerosis
Neurocritical Care
Neuroinfectious Disease
Neuromuscular
Neuro-oncology
Neuro-ophthalmology/Neuro-otology
Sleep Neurology
Sports Neurology/Concussion
At the Meetings
Meetings We Cover
Most Recent Meeting
About
About Neurology Today
Editorial Board
Subscription Services
Reprints
Rights and Permissions
About the AAN
American Academy of Neurology
Account
Register
Help
American Academy of Neurology
Login
Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.
Subscribe to eTOC
Home
>
Issue Outline
July 07, 2016
Volume 16, Issue 13
Browse Issues
For Your Patients
For Your Patients
Most Strokes Worldwide Caused by Modifiable Lifestyle Factors; Air Pollution Is to Blame for One-Third of Cases
For Your Patients
Intensive Treatment No Better Than Standard Treatment for Lowering Blood Pressure in People with Acute Intracerebral Hemorrhage
For Your Patients
The Premonitory Phase of Migraine: Bench to Bedside Insights
For Your Patients
News from the American Headache Society Annual Meeting: Men with Migraine Are Less Likely Than Women to Be Diagnosed and Treated
For Your Patients
Immunoablation Followed by Stem Cell Reconstitution Halts Aggressive MS for Five-Plus Years, But Adverse Events Remain a Concern
For Your Patients
Modified Alpha-Synuclein Impairs Mitochondrial Transport, New Study Finds: Why That Might Explain Parkinson's Disease Pathogenesis and Point to New Therapeutic Targets
For Your Patients
News from the American Headache Society Annual Meeting: Small-Molecule CGRP Antagonist Is Effective in Acute Treatment of Migraine, Study Finds
For Your Patients
News from the American Headache Society Annual Meeting: CGRP Drug Improves Wellness on Headache-Free Days, Study Finds
For Your Patients
News from the American Headache Society Annual Meeting: Five Years After Traumatic Brain Injury, One-Third of Patients Still Suffering Persistent Headaches
For Your Patients
News from the American Headache Society Annual Meeting: Smartphone App Captures Real-Time Migraine Medication Use Among Obese Women, Finding Nearly Half Go Untreated
Issue Cover
Editor's Pick Podcast
Back to Top
